S. Suissa, E. Moodie, and S. Dell'Aniello. Pharmacoepidemiology and drug safety, 26 (4):
459-468(April 2017)Propensity score; CER; New-user designs; Diabetis.
J. Robins, M. Hernán, and A. Rotnitzky. American journal of epidemiology, 166 (9):
994-1002; discussion 1003-4(November 2007)4950<m:linebreak></m:linebreak>GR: R01-HL080644/HL/NHLBI NIH HHS/United States; GR: R37-AI032475/AI/NIAID NIH HHS/United States; JID: 7910653; CON: Am J Epidemiol. 2007 Nov 1;166(9):985-93. PMID: 17875580; 2007/09/17 aheadofprint; ppublish;.
A. Jurek, S. Greenland, G. Maldonado, and T. Church. International journal of epidemiology, 34 (3):
680-7(June 2005)3939<m:linebreak></m:linebreak>Mesures d'associació.
D. Hartung, and D. Touchette. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 66 (4):
398-408(February 2009)6067<m:linebreak></m:linebreak>JID: 9503023; ppublish;<m:linebreak></m:linebreak>Disseny; Tipus d'estudis.
K. Flegal, B. Graubard, and D. Williamson. American journal of epidemiology, 160 (4):
331-8(August 2004)4391<m:linebreak></m:linebreak>LR: 20041117; PUBM: Print; JID: 7910653; ppublish;<m:linebreak></m:linebreak>Risc atribuïble.